Boulegeris Investments’s Bristol-Myers Squibb BMY Stock Holding History

Boulegeris Investments’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-53,248	Closed	-$2.95M	–	8
2018 Q2	$2.95M	Buy	53,248 +3,970	+8%	+$214K	1.47%	18
2018 Q1	$3.12M	Buy	49,278 +290	+0.6%	+$18.7K	1.71%	18
2017 Q4	$3M	Sell	48,988 -2,035	-4%	-$127K	1.56%	16
2017 Q3	$3.25M	Buy	51,023 +4,685	+10%	+$274K	1.81%	12
2017 Q2	$2.58M	Buy	46,338 +1,430	+3%	+$77.8K	1.46%	14
2017 Q1	$2.44M	Buy	44,908 +8,188	+22%	+$449K	1.46%	14
2016 Q4	$2.15M	Buy	36,720 +6,221	+20%	+$340K	1.3%	17
2016 Q3	$1.65M	Buy	30,499 +11,614	+61%	+$746K	1.04%	21
2016 Q2	$1.39M	Buy	18,885 +14,615	+342%	+$1.03M	0.95%	24
2016 Q1	$273K	Buy	+4,270	New	+$269K	0.19%	45

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Boulegeris Investments's BMY Position: Q3 2018 in Review

Boulegeris Investments sold out of Bristol-Myers Squibb (BMY) in Q3 2018, closing a stake of 53,248 shares — an estimated $2.95M sold.

Boulegeris Investments first reported a position in BMY in Q1 2016 and held it in 10 quarters. The position peaked at $3.25M in Q3 2017. 1,729 funds tracked by Wall St. Rank hold BMY as of Q3 2018.

Boulegeris Investments reported no remaining Bristol-Myers Squibb position as of Q3 2018 after selling out during the quarter.
Boulegeris Investments sold 53,248 Bristol-Myers Squibb shares in Q3 2018, an estimated $2.95M.
Boulegeris Investments first reported a position in Bristol-Myers Squibb in Q1 2016 and held it in 10 quarters.
Boulegeris Investments's Bristol-Myers Squibb position peaked at $3.25M in Q3 2017.
1,729 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2018.

Based on Boulegeris Investments's 13F filing for Q3 2018.